Optimizing the Use of Electronic Data Sources in Clinical Trials: The Landscape, Part 1

Conclusions:
Based on survey results, companies generally have taken steps to leverage current eSource technologies and prepare for optimal utilization of electronic data sources. The TransCelerate eSource Initiative will continue to evaluate the technology, regulatory, standards, and health care landscape to support the goal of improving global clinical science and global clinical trial execution. Forthcoming publications will focus on technology landscape, future vision, and demonstration projects.

Source: Therapeutic Innovation and Regulatory Science - October 23, 2016 Category: Drugs & Pharmacology Authors: Kellar, E., Bornstein, S. M., Caban, A., Celingant, C., Crouthamel, M., Johnson, C., McIntire, P. A., Milstead, K. R., Patterson, J. K., Wilson, B. Tags: Sponsored Special Section by TransCelerate BioPharma Source Type: research